CHARLESTON, S.C., April 4 /PRNewswire/ -- JSJ Pharmaceuticals is pleased to announce that, as part of its long-term brand life cycle management, it has reached an agreement with an undisclosed generic pharmaceutical partner to provide authorized generic versions of JSJ brands. While such an arrangement is important to the late stages of a brand's life cycle, it is critical that long-term planning is in place for rapid strategic execution. "At some point, a brand will lose its market exclusivity; an authorized generic partner provides JSJ with an important tool in the late-stage life cycle management of its brands and will let us respond quickly to changes in market conditions," stated JSJ's Chief Operating Officer, Jonathan Alba.
JSJ Pharmaceuticals is a growing specialty pharmaceutical company focused on the development and commercialization of prescriptive products to meet the diverse needs of patients suffering from a wide range of dermatological conditions. More information can be found about JSJ Pharmaceuticals at http://www.jsjpharm.com.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
JSJ Pharmaceuticals, Inc.
CONTACT: Jon Knowles of JSJ Pharmaceuticals, Inc., +1-843-965-8333ext.104, email@example.com